Month: January 2024

Samsung Biologics selects Rapid Micro Biosystems’ Growth Direct® platform to automate critical microbiology quality control testing

Companies share commitment to innovating quality control processes to meet biomanufacturing challenges such as scale, data integrity and accelerating time to market LOWELL, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and […]

Continue Reading »

Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025

Company well-positioned for further progress and broadening of R&D pipeline Cash resources of approximately $455 million as of December 31, 2023 (unaudited) Expected cash runway, including proceeds from recent private placement, into 2H 2027 Top-line data readout from the Phase 3 trial evaluating zanidatamab in HER2-positive gastroesophageal adenocarcinoma (GEA), HERIZON-GEA-01, expected in 2024 Expected regulatory […]

Continue Reading »

Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025

Company well-positioned for further progress and broadening of R&D pipeline Cash resources of approximately $455 million as of December 31, 2023 (unaudited) Expected cash runway, including proceeds from recent private placement, into 2H 2027 Top-line data readout from the Phase 3 trial evaluating zanidatamab in HER2-positive gastroesophageal adenocarcinoma (GEA), HERIZON-GEA-01, expected in 2024 Expected regulatory […]

Continue Reading »

Zymeworks Announces Additional Leadership Appointments

Dr. Jeffrey Smith named Executive Vice President and Chief Medical Officer Dr. John Fann promoted to Senior VP, Process Sciences Seven new Vice Presidents appointed, underscoring commitment to leadership development VANCOUVER, British Columbia, Jan. 04, 2024 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics […]

Continue Reading »

Copenhagen Infrastructure Partners awarded preferred bidder status for three battery energy storage projects in South Africa

Mulilo Energy Holdings (Pty) (“Mulilo”), majority owned by Copenhagen Infrastructure Partners (“CIP”), has in partnership with EDF Renewables (Pty) Ltd (“EDF”) been awarded preferred bidder status for three battery energy storage projects totaling 1,028 MWh / 257 MW in South Africa COPENHAGEN, Denmark, Jan. 04, 2024 (GLOBE NEWSWIRE) — A consortium consisting of Mulilo, a […]

Continue Reading »